Tuhura Biosciences Stock Last Dividend Paid
| HURA Stock | 6.56 1.51 29.90% |
TuHURA Biosciences fundamentals help investors to digest information that contributes to TuHURA Biosciences' financial success or failures. It also enables traders to predict the movement of TuHURA Stock. The fundamental analysis module provides a way to measure TuHURA Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to TuHURA Biosciences stock.
TuHURA | Last Dividend Paid |
TuHURA Biosciences Company Last Dividend Paid Analysis
TuHURA Biosciences' Last Dividend Paid refers to dividend per share(DPS) paid to the shareholder the last time dividends were issued by a company. In its conventional sense, dividends refer to the distribution of some of a company's net earnings or capital gains decided by the board of directors.
More About Last Dividend Paid | All Equity Analysis
Last Dividend | = | Last Profit Distribution AmountTotal Shares |
TuHURA Last Dividend Paid Driver Correlations
Understanding the fundamental principles of building solid financial models for TuHURA Biosciences is extremely important. It helps to project a fair market value of TuHURA Stock properly, considering its historical fundamentals such as Last Dividend Paid. Since TuHURA Biosciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of TuHURA Biosciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of TuHURA Biosciences' interrelated accounts and indicators.
Click cells to compare fundamentals
Many stable companies today pay out dividends to their shareholders in the form of the income distribution, but high-growth firms rarely offer dividends because all of their earnings are reinvested back to the business.
| Competition |
Based on the recorded statements, TuHURA Biosciences has a Last Dividend Paid of 0.0. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
TuHURA Last Dividend Paid Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses TuHURA Biosciences' direct or indirect competition against its Last Dividend Paid to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of TuHURA Biosciences could also be used in its relative valuation, which is a method of valuing TuHURA Biosciences by comparing valuation metrics of similar companies.TuHURA Biosciences is currently under evaluation in last dividend paid category among its peers.
TuHURA Biosciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of TuHURA Biosciences from analyzing TuHURA Biosciences' financial statements. These drivers represent accounts that assess TuHURA Biosciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of TuHURA Biosciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Market Cap | 498.7M | 115.3M | 2.1B | 390.7M | 351.6M | 587.5M | |
| Enterprise Value | 492.7M | 111.6M | 2.0B | 376.5M | 338.9M | 321.9M |
TuHURA Fundamentals
| Current Valuation | 281.53 M | ||||
| Shares Outstanding | 26 M | ||||
| Number Of Shares Shorted | 137.52 K | ||||
| Price To Book | 195.89 X | ||||
| EBITDA | (29.12 M) | ||||
| Net Income | (29.32 M) | ||||
| Total Debt | 2.34 M | ||||
| Cash Flow From Operations | (7.18 M) | ||||
| Target Price | 15.0 | ||||
| Market Capitalization | 141.65 M | ||||
| Total Asset | 4.36 M | ||||
| Retained Earnings | (88.47 M) | ||||
| Working Capital | 562.42 K | ||||
| Net Asset | 4.36 M |
About TuHURA Biosciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze TuHURA Biosciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of TuHURA Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of TuHURA Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether TuHURA Biosciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of TuHURA Biosciences' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Tuhura Biosciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Tuhura Biosciences Stock:Check out TuHURA Biosciences Piotroski F Score and TuHURA Biosciences Altman Z Score analysis. For information on how to trade TuHURA Stock refer to our How to Trade TuHURA Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of TuHURA Biosciences. If investors know TuHURA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about TuHURA Biosciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of TuHURA Biosciences is measured differently than its book value, which is the value of TuHURA that is recorded on the company's balance sheet. Investors also form their own opinion of TuHURA Biosciences' value that differs from its market value or its book value, called intrinsic value, which is TuHURA Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because TuHURA Biosciences' market value can be influenced by many factors that don't directly affect TuHURA Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between TuHURA Biosciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if TuHURA Biosciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, TuHURA Biosciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.